業績 Publications
原著論文 Original papers
太字は所属教員を示す。
2026年
- Kirara Inoue, Tsutomu Matsubara, Hayato Urushima, Hideto Yuasa, Atsuko Daikoku, Kazuo Ikeda, Norifumi Kawada, Katsutoshi Yoshizato, Takayuki Suzuki and Misako Sato-Matsubara*. A Hepatocyte Membrane-Based Culture System Recapitulating the Physiological Microenvironment of Hepatic Stellate Cells. American Journal of Physiology–Cell Physiology, 2026, 330 (2), C434–C447.
- Hiroko Ikenaga, Ritsuzo Kozuka, Kirara Inoue, Tsutomu Matsubara, Naoshi Odagiri, Kanako Yoshida, Kohei Kotani, Etsushi Kawamura, Atsushi Hagihara, Hideki Fujii, Masaru Enomoto, Sawako Uchida-Kobayashi*. 12-Hydroxyheptadecatrienoic Acid Predicts Hepatocellular Carcinoma Development During Nucleos(t)ide Analogue Therapy. Cancers, 2026, 18(4), 542.
2025年
- Yutaka Yasui, Misako Sato-Matsubara, Masaru Enomoto, Tsutomu Matsubara, Mana Kosugi, Kirara Inoue, Truong Huu Hoang, Hideto Yuasa, Hideki Fujii, Atsuko Daikoku, Yoshihiro Ikura, Etsushi Kawamura, Sawako Uchida-Kobayashi, Akihiro Tamori, Norifumi Kawada*. Plasma fibulin-5 as a novel marker for advanced fibrosis in chronic hepatitis C. Gastro Hep Advances, 2025, 2(5), 100827.
- Masako Okada, Misako Sato-Matsubara, Masaru Enomoto, Truong Huu Hoang, Sawako Uchida-Kobayashi, Akihiro Tamori, Tsutomu Matsubara, Kenichi Kohashi, Takeaki Ishizawa, Norifumi Kawada*. Prognostic Significance of Poly (ADP-Ribose) Polymerase 1 Binding Protein Expression and CD8+ Tumor-Infiltrating Lymphocytes in Hepatocellular Carcinoma. Laboratory investigation; a journal of technical methods and pathology, 2025, 105(11) 104226-104226.
- Atsuko Daikoku, Tsutomu Matsubara, Misako Sato-Matsubara, Miku Ando, Chiho Kadono, Sayuri Takada, Naoshi Odagiri, Hideto Yuasa, Hayato Urushima, Katsutoshi Yoshizato, Norifumi Kawada, Kazuo Ikeda*. Lawsone can suppress liver fibrosis by inhibition of YAP signaling and induction of CYGB expression in hepatic stellate cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2025, 191 118520-118520.
2024年
2023年
- Yoshinori Okina, Misako Sato-Matsubara, Yasutoshi Kido, Hayato Urushima, Atsuko Daikoku, Chiho Kadono, Yu Nakagama, Yuko Nitahara, Truong Huu Hoang, Le Thi Thanh Thuy, Tsutomu Matsubara, Naoko Ohtani, Kazuo Ikeda, Katsutoshi Yoshizato, Norifumi Kawada*. Nitric oxide derived from cytoglobin-deficient hepatic stellate cells causes suppression of cytochrome c oxidase activity in hepatocytes. Antioxidants & redox signaling, 2023,38(7-9) 463-479.
- Truong Huu Hoang, Misako Sato-Matsubara, Hideto Yuasa, Tsutomu Matsubara, Le Thi Thanh Thuy, Hiroko Ikenaga, Dong Minh Phuong, Ngo Vinh Hanh, Vu Ngoc Hieu, Dinh Viet Hoang,
- 井上喜来々、河田則文*、肝細胞膜による肝星細胞活性化抑制の分子機序、日本門脈圧亢進症学会雑誌、2023年、29(2) 127-133.
2022年
- Hieu VN, Thuy LTT, Hai H, Dat NQ, Hoang DV, Hanh NV, Phuong DM, Hoang TH, Sawai H, Yoshitsugu S, Sato-Matsubara M, Oikawa D, Tokunaga F, Yoshizato K, Kawada N*. Capacity of extracellular globins to reduce liver fibrosis via scavenging reactive oxygen species and promoting MMP-1 secretion. Redox Biology, 2022, Vol 52,102286.
- Minh Phuong Dong, Le Thi Thanh Thuy, Dinh Viet Hoang, Hoang Hai, Truong Huu Hoang, Misako Sato-Matsubara, Vu Ngoc Hieu, Atsuko Daikoku, Ngo Vinh Hanh, Hayato Urushima, Ninh Quoc Dat, Sawako Uchida-Kobayashi, Masaru Enomoto, Naoko Ohtani, Akihiro Tamori, Norifumi Kawada*. Soluble immune checkpoint protein CD27 is a novel prognostic biomarker of HCC development in HCV-SVR patients. The American journal of pathology, 2022, 192(10) 1379-1396.
- Katsutoshi Yoshizato, Toshio Taira, Misako Sato-Matsubara, Shizuko Sekiguchi, Yoriko Yabunaka, Yukimi Kira, Tetsu Ohashi, Atsuko Daikoku, Ken Ofusa, Chiho Kadono, Cloaking the ACE2 receptor with salivary cationic proteins inhibits SARS-CoV-2 entry. Journal of biochemistry, 2022, 172(4) 205-216.
- Dinh Viet Hoang, Le Thi Thanh Thuy, Hoang Hai, Vu Ngoc Hieu, Kenjiro Kimura, Daisuke Oikawa, Yoshihiro Ikura, Ninh Quoc Dat, Truong Huu Hoang, Misako Sato-Matsubara, Minh Phuong Dong, Ngo Vinh Hanh, Sawako Uchida-Kobayashi, Fuminori Tokunaga, Shoji Kubo, Naoko Ohtani, Katsutoshi YoshizatoCytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species. Oncogenesis, 2022, 11(1) 23-23.
2021年
- Takada S, Matsubara T*, Fujii H, Sato-Matsubara M, Daikoku A, Odagiri N, Amano-Teranishi Y, Kawada N, Ikeda K. Stress can attenuate hepatic lipid accumulation via elevation of hepatic β-muricholic acid levels in mice with nonalcoholic steatohepatitis. Lab Invest, 2021;101(2):193-203.
- Dat, NQ, Thuy LTT, Hieu VN, Hai H, Hoang DV, Hai NTT, Thuy TTV, Komiya T, Rombouts K, Dong MP, Hanh NV, Hoang TH, Sato-Matsubara M, Daikoku A, Kadono C, Oikawa D, Yoshizato K, Tokunaga F, Pinzani M, Kawada N*. (2021). Hexa Histidine-Tagged Recombinant Human Cytoglobin Deactivates Hepatic Stellate Cells and Inhibits Liver Fibrosis by Scavenging Reactive Oxygen Species. Hepatology, 73(6): 2527-2545.
- Odagiri N, Matsubara T, Sato-Matsubara M, Fujii H, Enomoto M, Kawada N*. Anti-fibrotic treatments for chronic liver diseases: The present and the future. Clin Mol Hepatol, 2021;27(3):413-424.
2020年
- 松原三佐子、吉里則文、河田則文*、抗線維化薬開発の最新情報、総説、日本消化器病学会誌 2020 117(1) 52-63.
- Okina Y, Sato-Matsubara M, Matsubara T, Daikoku A, Longato L, Rombouts K, Thanh Thuy LT, Ichikawa H, Minamiyama Y, Kadota M, Fujii H, Enomoto M, Ikeda K, Yoshizato K, Pinzani M, Kawada N*. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis. J Hepatol, 2020;73(4):882-895. (共同筆頭著者)
2019年
- 松原三佐子、吉里則文、河田則文*、肝星細胞活性化と肝硬変・肝がん、細胞、肝星細胞の活性化の仕組み、サイトグロビンの作用から見えてくる新しい視点、2019 51(11) 530-534.
- Kozuka R, Enomoto M, Sato-Matsubara M, Yoshida K, Motoyama H, Hagihara A, Fujii H, Uchida-Kobayashi S, Morikawa H, Tamori A, Kawada N, Murakami Y*. Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatment. J Gastroenterol Hepatol, 2019 May;34(5):937-946.
2018年
- Thi Thanh Hai N, Thuy LTT, Shiota A, Kadono C, Daikoku A, Hoang DV, Dat NQ, Sato-Matsubara M, Yoshizato K, Kawada N*. Selective overexpression of cytoglobin in stellate cells attenuates thioacetamide-induced liver fibrosis in mice. Sci Rep, 2018 Dec 14;8(1):17860.
- 松原三佐子、河田則文*、肝硬変、肝線維化、肝疾患における新薬開発の動向 消化器疾患の最新医療、先端医療シリーズ 2018, 49, 214-219.
2017年
- Sato-Matsubara M, Matsubara T, Daikoku A, Okina Y, Longato L, Rombouts K, Thuy LTT, Adachi J, Tomonaga T, Ikeda K, Yoshizato K, Pinzani M, Kawada N*. Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling. J Biol Chem, 2017;292(46):18961-18972.
- Matsuura K, Sawai H, Ikeo K, Ogawa S, Iio E, Isogawa M, Shimada N, Komori A, Sato-Matsubara M, *Tanaka Y.「他25名」Genome-wide association study identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus infection. Gastroenterology, 2017,52:1383-1394.
- 松原三佐子、河田則文*、サイトグロビンと肝疾患 医学のあゆみ:TOPICS, 2017, 261, 829-830